(Fighting New Coronary Pneumonia) Pfizer and BioNTech submit a new crown vaccine application to the EU, Germany is expected to start vaccination in January
China News Agency, Berlin, December 1 (Reporter Peng Dawei) German BioNTech and Pfizer announced on the 1st that they have formally applied for a conditional marketing license to the European Medicines Agency for their jointly developed mRNA COVID-19 vaccine. CMA), is expected to be approved before the end of the year.
German Health Minister Span said on the same day that it is expected that Germany will be able to vaccinate the first high-risk groups and medical staff with the new crown vaccine in January next year.
The BNT162b2 new crown vaccine jointly developed by German Biotech and Pfizer of the United States uses messenger ribonucleic acid (mRNA) technology.
The results of Phase III clinical trials show that this vaccine is 95% effective.
The two companies stated that they have submitted conditional marketing authorization or emergency use applications to the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA) and the British Medicines and Healthcare Products Administration (MHRA), and have already applied for a conditional marketing authorization or emergency use in Australia. , Canada and Japan have initiated mobile submission procedures and plan to apply to regulatory agencies in other countries around the world.
According to a report from German TV, on the same day, Modena of the United States also submitted a conditional marketing authorization application to the European Medicines Agency for its new crown vaccine.
German Health Minister Span told German media that the German government's goal is to vaccinate the first group of high-risk groups and medical staff with the new crown vaccine by January next year.
By mid-December this year, all the vaccination centers set up in the German states will be ready.
By the summer of next year, Germans will be able to receive the new crown vaccine in general clinics.
Shi Pan emphasized that the first to be vaccinated should be the elderly and those with underlying diseases.
Starting from December 1, Germany began to implement upgraded anti-epidemic measures.
From that day to December 20, private gatherings only allow up to two families with no more than 5 people to participate. At the same time, the scope of the mask enforcement order has also been extended to all public places.
Germany's current round of "cities lockdown" has been implemented since November 2, and the number of newly diagnosed new coronavirus infections in a single day has begun to decline significantly.
The German disease control department announced on the 1st that the number of new confirmed cases was 13,604.
German "Times Online" real-time data as of 18:00 on the 1st showed that a total of 1,079,713 confirmed cases, 758,627 cured, and 16,963 died in Germany.
(Finish)